Sana Biotechnology Statistics Share Statistics Sana Biotechnology has 237.5M
shares outstanding. The number of shares has increased by 1.39%
in one year.
Shares Outstanding 237.5M Shares Change (YoY) 1.39% Shares Change (QoQ) 0.24% Owned by Institutions (%) 62.81% Shares Floating 144.54M Failed to Deliver (FTD) Shares 2,611 FTD / Avg. Volume 0.05%
Short Selling Information The latest short interest is 33.35M, so 13.14% of the outstanding
shares have been sold short.
Short Interest 33.35M Short % of Shares Out 13.14% Short % of Float 39.14% Short Ratio (days to cover) 4.5
Valuation Ratios The PE ratio is -1.41 and the forward
PE ratio is -4.52.
Sana Biotechnology's PEG ratio is
0.07.
PE Ratio -1.41 Forward PE -4.52 PS Ratio 0 Forward PS n/a PB Ratio 1.5 P/FCF Ratio -1.47 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Sana Biotechnology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.54,
with a Debt / Equity ratio of 0.38.
Current Ratio 3.54 Quick Ratio 3.54 Debt / Equity 0.38 Debt / EBITDA -0.37 Debt / FCF -0.37 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.38M Employee Count 194 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -41.27% in the
last 52 weeks. The beta is 1.89, so Sana Biotechnology's
price volatility has been higher than the market average.
Beta 1.89 52-Week Price Change -41.27% 50-Day Moving Average 3.7 200-Day Moving Average 2.7 Relative Strength Index (RSI) 39.39 Average Volume (20 Days) 5,685,003
Income Statement
Revenue n/a Gross Profit -15.49M Operating Income -272.72M Net Income -266.76M EBITDA -251.27M EBIT -266.76M Earnings Per Share (EPS) -1.16
Full Income Statement Balance Sheet The company has 127.57M in cash and 94.2M in
debt, giving a net cash position of 33.37M.
Cash & Cash Equivalents 127.57M Total Debt 94.2M Net Cash 33.37M Retained Earnings -1.6B Total Assets 361.64M Working Capital 49.06M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -223.15M
and capital expenditures -33.43M, giving a free cash flow of -256.58M.
Operating Cash Flow -223.15M Capital Expenditures -33.43M Free Cash Flow -256.58M FCF Per Share -1.11
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
